SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

PURSUANT TO RULE 13A-16 OR 15-D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For March 31, 2008

 

Commission File Number 000-17434

 

DRAXIS HEALTH INC.

(Translation of registrant’s name into English)

 

Suite 4700, TD Bank Tower

Toronto Dominion Centre

Toronto, Ontario M5K 1E6

CANADA

(Address of principal offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

 

 

 

Form 20-F    x

 

Form 40-F    o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  o

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

 

 

 

Yes    o

 

No    x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

 

 

 



 

EXHIBITS LIST

 

99.1         Annual Report

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

DRAXIS HEALTH INC.

 

 

 

 

 

/s/ ALIDA GUALTIERI

 

Alida Gualtieri

 

General Counsel & Secretary

 

 

Dated:

March 31, 2008

 

 

2


Draxis Health (MM) (NASDAQ:DRAX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Draxis Health (MM) Charts.
Draxis Health (MM) (NASDAQ:DRAX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Draxis Health (MM) Charts.